J&J lays out plan to splinter orthopedics business into separate company

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business. The health care giant said Tuesday that it will separate its orthopedics business into a standalone company known as DePuy Synthes. The move leaves J&J focused on its pharmaceutical and MedTech segments, which make prescription drugs, contact lenses and technology to treat cardiovascular disease and help with surgeries.